ProfileGDS4718 / 222244_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 94% 96% 94% 95% 94% 93% 93% 95% 94% 92% 95% 83% 94% 92% 93% 95% 95% 94% 98% 93% 93% 93% 93% 94% 93% 95% 98% 96% 95% 93% 93% 95% 94% 94% 94% 95% 95% 94% 95% 93% 95% 95% 95% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.474995
GSM549102patient 115, normal, homogenized [OPG study]10.021794
GSM549104patient 119, normal, homogenized [OPG study]10.49896
GSM549108patient 138, normal, homogenized [OPG study]10.076194
GSM549119patient 077, normal, homogenized [OPG study]10.281195
GSM549133patient 032, cancer, homogenized [OPG study]10.026894
GSM549139patient 042, cancer, homogenized [OPG study]9.7232493
GSM549099patient 107, normal, homogenized [OPG study]9.8166793
GSM549109patient 139, normal, homogenized [OPG study]10.440395
GSM549110patient 046, normal, homogenized [OPG study]10.071594
GSM549114patient 063, normal, homogenized [OPG study]9.8316692
GSM549122patient 082, normal, homogenized [OPG study]10.166295
GSM549134patient 033, cancer, homogenized [OPG study]8.2056183
GSM549136patient 036, cancer, homogenized [OPG study]10.091894
GSM549140patient 044, cancer, homogenized [OPG study]9.5332992
GSM549111patient 047, normal, homogenized [OPG study]9.9232793
GSM549113patient 057, normal, homogenized [OPG study]10.316795
GSM549132patient 031, cancer, homogenized [OPG study]10.089995
GSM549137patient 038, cancer, homogenized [OPG study]9.8136194
GSM549142patient 047, cancer, homogenized [OPG study]10.9598
GSM549100patient 110, normal, homogenized [OPG study]9.8515693
GSM549107patient 135, normal, homogenized [OPG study]9.8655693
GSM549115patient 068, normal, homogenized [OPG study]10.095693
GSM549116patient 072, normal, homogenized [OPG study]9.9335793
GSM549120patient 078, normal, homogenized [OPG study]10.023394
GSM549131patient 030, cancer, homogenized [OPG study]9.7987993
GSM549118patient 074, normal, homogenized [OPG study]10.201895
GSM549129patient 027, cancer, homogenized [OPG study]11.214998
GSM549123patient 088, normal, homogenized [OPG study]10.62296
GSM549124patient 006, cancer, homogenized [OPG study]10.088295
GSM549126patient 015, cancer, homogenized [OPG study]9.6028993
GSM549128patient 025, cancer, homogenized [OPG study]9.7998793
GSM549103patient 117, normal, homogenized [OPG study]10.354195
GSM549117patient 073, normal, homogenized [OPG study]10.19694
GSM549138patient 041, cancer, homogenized [OPG study]9.9313894
GSM549141patient 045, cancer, homogenized [OPG study]10.038294
GSM549130patient 028, cancer, homogenized [OPG study]10.179995
GSM549101patient 111, normal, homogenized [OPG study]10.235595
GSM549105patient 128, normal, homogenized [OPG study]9.8673794
GSM549106patient 134, normal, homogenized [OPG study]10.425895
GSM549112patient 048, normal, homogenized [OPG study]9.9038493
GSM549125patient 011, cancer, homogenized [OPG study]10.068995
GSM549127patient 024, cancer, homogenized [OPG study]10.103495
GSM549135patient 035, cancer, homogenized [OPG study]10.138395